glp-1 and glp-2 drugs medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1 -slash-risk-4-types-cancer-50-or-more-study difference between glp-1 and glp-2

Weight loss depends on: Starting body weight Medication dose Diet Physical activity Sleep Consistency Average weight loss reported in clinical studies: Some individuals lose even more weight when lifestyle modifications are maintained

GLP-1 Up works with your body, not against it

A phase 2 trial assessing different doses of bimagrumab (up to 30 mg/kg) in combination with semaglutide as obesity treatment is ongoing (NCT05616013)

For these reasons, most medical guidelines recommend postponing pharmacological weight loss interventions until after breastfeeding concludes, unless maternal health risks make immediate intervention necessary and appropriate medical oversight is in place

Since liraglutide is 97% homologous to natural GLP-1, the incidence of antibodies tested in the phase 3 clinical study was relatively low, with elevated antibody levels detected in less than 10% of individuals